BlackRock’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.9M | Buy |
|
|||||
|
2025
Q1 | $29.4M | Buy |
|
|||||
|
2024
Q4 | $28.7M | Sell |
|
|||||
|
2024
Q3 | $20.1M | Buy |
|
|||||
|
2024
Q2 | $11.9M | Buy |
|
|||||
|
2024
Q1 | $4.65M | Sell |
|
|||||
|
2023
Q4 | $3.87M | Buy |
|
|||||
|
2023
Q3 | $2.8M | Sell |
|
|||||
|
2023
Q2 | $2.5M | Buy |
|
|||||
|
2023
Q1 | $1.52M | Sell |
|
|||||
|
2022
Q4 | $1.69M | Sell |
|
|||||
|
2022
Q3 | $1.36M | Sell |
|
|||||
|
2022
Q2 | $1.53M | Sell |
|
|||||
|
2022
Q1 | $10M | Sell |
|
|||||
|
2021
Q4 | $31.9M | Buy |
|
|||||
|
2021
Q3 | $40.5M | Buy |
|
|||||
|
2021
Q2 | $49.9M | Buy |
|
|||||
|
2021
Q1 | $41.9M | Buy |
|
|||||
|
2020
Q4 | $31.9M | Sell |
|
|||||
|
2020
Q3 | $29.5M | Buy |
|
|||||
|
2020
Q2 | $154M | Buy |
|
|||||
|
2020
Q1 | $76.8M | Sell |
|
|||||
|
2019
Q4 | $64.9M | Sell |
|
|||||
|
2019
Q3 | $41.5M | Buy |
|
|||||
|
2019
Q2 | $49.5M | Buy |
|
|||||
|
2019
Q1 | $69.5M | Buy |
|
|||||
|
2018
Q4 | $45.9M | Buy |
|
|||||
|
2018
Q3 | $46.5M | Buy |
|
|||||
|
2018
Q2 | $50M | Buy |
|
|||||
|
2018
Q1 | $41M | Buy |
|
|||||
|
2017
Q4 | $58.1M | Buy |
|
|||||
|
2017
Q3 | $73.8M | Buy |
|
|||||
|
2017
Q2 | $39.4M | Buy |
|
|||||
|
2017
Q1 | $24.7M | Buy |
|
|||||
|
2016
Q4 | $80K | Buy |
|
|||||
|
2016
Q3 | $65K | Buy |
|
|||||
|
2016
Q2 | $50K | Buy |
|
|||||
|
2016
Q1 | $20K | Sell |
|
|||||
|
2015
Q4 | $71K | Buy |
|
|||||
|
2015
Q3 | $51K | Buy |
|
|||||
|
2015
Q2 | $3K | Hold |
|
|||||
|
2015
Q1 | $3K | Hold |
|
|||||
|
2014
Q4 | $3K | Hold |
|
|||||
|
2014
Q3 | $6K | Sell |
|
|||||
|
2014
Q2 | $326K | Buy |
|